As of 2025-06-30, the Intrinsic Value of Longboard Pharmaceuticals Inc (LBPH) is -9.78 USD. This LBPH valuation is based on the model Peter Lynch Fair Value. With the current market price of 59.98 USD, the upside of Longboard Pharmaceuticals Inc is -116.30%.
Based on its market price of 59.98 USD and our intrinsic valuation, Longboard Pharmaceuticals Inc (LBPH) is overvalued by 116.30%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.78 - -9.78 | -9.78 | -116.30% |
| P/E | (34.76) - (35.74) | (35.87) | -159.8% |
| DDM - Stable | (23.38) - (99.56) | (61.47) | -202.5% |
| DDM - Multi | (16.27) - (53.63) | (24.94) | -141.6% |
| Market Cap (mil) | 2,342.22 |
| Beta | -3.43 |
| Outstanding shares (mil) | 39.05 |
| Enterprise Value (mil) | 2,314.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.81% |
| Cost of Debt | 5.00% |
| WACC | 5.74% |